COMPANY PROFILE · UPDATED 01 AUG 2026

Rapport Therapeutics

Rapport Therapeutics operates as a clinical-stage biotechnology company, that discovers and develops precision medicines for neurological disorders. Rapport Therapeutics describes relationships that are defined by understanding,…

rapportrx.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2022
Headcount: 43
Open roles: 18
Last raised: Post Ipo Equity · Sign in to view

TECH STACK

How Rapport Therapeutics builds

LEADERSHIP

Founders & key people

OPEN ROLES

Hiring at Rapport Therapeutics

View all 18 open roles →

FUNDING

Capital raised

Total raised

$500,000,000

Investors

Arch Venture PartnersCormorant Asset ManagementFidelityGoldman Sachs Asset ManagementJohnson & Johnson InnovationLogos CapitalPerceptive AdvisorsSofinnova VenturesSurveyor CapitalT. Rowe PriceThird Rock Ventures

Funding rounds

Post Ipo Equity
$250MSep 9, 2025
IPO
UndisclosedJan 1, 2024
Series B
Cormorant Asset Management, Arch Venture Partners, Fidelity, Logos Capital, Third Rock Ventures, Perceptive Advisors, Goldman Sachs Asset Management, Surveyor Capital, Johnson & Johnson Innovation, Sofinnova Ventures, T. Rowe Price
$150MAug 22, 2023
Series A
Third Rock Ventures, Arch Venture Partners, Johnson & Johnson Innovation
$100MMar 6, 2023

Funding data via Diffbot

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Industries

Medical Organizations Health Care Companies Biotechnology Companies

Tech Stack

Mysql Php Wordpress

LOCATIONS

Where they work

Rapport Therapeutics offices

Loading map…

Boston, MA201 Brookline Avenue suite 1401